Caspofungin study enrollment criteria

Author: 

Maertens J, Raad I, Sable CA, Ngai A, Berman R, Patterson TF, Denning DW, Walsh T.
The Medscape Journal; 20 Mar 2006

Abstract: 

noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory (R) or intolerant (I) to amphotericin B (AMB), AMB lipid formulations (lipid AMB), or azoles. Interscience Conference on Antimicrobial Agents and Chemotherapy.